Budesonide/Formoterol Pressurized Metered-Dose Inhaler versus Budesonide: A Randomized Controlled Trial in Black Patients with Asthma

References

• American Lung Association. Trends in asthma morbidity and mortality. July 2011. Available at: http://www.lungusa.org. Accessed October 20, 2009.
   Google Scholar
• Centers for Disease Control and Prevention. National Health Interview Survey (NHIS) data. 2008. Available at: http://www.cdc.gov/asthma/nhis/08/table2-1.htm. Accessed September 29, 2010.
   Google Scholar
• Ginde AA, Espinola JA, Camargo Jr. CA. Improved overall trends but persistent racial disparities in emergency department visits for acute asthma, 1993–2005. J Allergy Clin Immunol 2008; 122(2):313–318.
   PubMed Web of Science ®Google Scholar
• Lang DM, Polansky M, Sherman MS. Hospitalizations for asthma in an urban population: 1995–1999. Ann Allergy Asthma Immunol 2009; 103(2):128–133.
   PubMedGoogle Scholar
• Zoratti EM, Havstad S, Rodriguez J, Robens-Paradise Y, Lafata JE, McCarthy B. Health service use by African Americans and Caucasians with asthma in a managed care setting. Am J Respir Crit Care Med 1998; 158(2):371–377.
   PubMed Web of Science ®Google Scholar
• Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM, the SMART Study Group. The salmeterol multicenter asthma research trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006; 129(1):15–26.
   Google Scholar
• Bleecker ER, Yancey SW, Baitinger LA, Edwards LD, Klotsman M, Anderson WH, Dorinsky PM. Salmeterol response is not affected by β2-adrenergic receptor genotype in subjects with persistent asthma. J Allergy Clin Immunol 2006; 118(4):809–816.
   PubMed Web of Science ®Google Scholar
• Bleecker ER, Postma DS, Lawrence RM, Meyers DA, Ambrose HJ, Goldman M. Effect of ADRB2 polymorphisms on response to longacting β2-agonist therapy: a pharmacogenetic analysis of two randomized studies. Lancet 2007; 370(9605):2118–2125.
   PubMed Web of Science ®Google Scholar
• Bleecker ER, Nelson HS, Kraft M, Corren J, Meyers DA, Yancey SW, Anderson WH, Emmett AH, Ortega HG. β2-Receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate. Am J Respir Crit Care Med 2010; 181(7):676–687.
   PubMed Web of Science ®Google Scholar
• Wechsler ME, Kunselman SJ, Chinchilli VM, Bleecker E, Boushey HA, Calhoun WJ, Ameredes BT, Castro M, Craig TJ, Denlinger L, Fahy JV, Jarjour N, Kazani S, Kim S, Kraft M, Lazarus SC, Lemanske Jr. RF, Markezich A, Martin RJ, Permaul P, Peters SP, Ramsdell J, Sorkness CA, Sutherland ER, Szefler SJ, Walter MJ, Wasserman SI, Israel E, for the National Heart, Lung, and Blood Institute’s Asthma Clinical Research Network. Effect of β2-adrenergic receptor polymorphism on response to longacting β2 agonist in asthma (LARGE trial): a genotype-stratified, randomized, placebo-controlled, crossover trial. Lancet 2009; 374(9703):1754–1764.
   PubMed Web of Science ®Google Scholar
• Corren J, Korenblat PE, Miller CJ, O’Brien CD, Mezzanotte WS. Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma. Clin Ther 2007; 29(5):823–843.
   PubMed Web of Science ®Google Scholar
• Noonan M, Rosenwasser LJ, Martin P, O’Brien CD, O’Dowd L. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. Drugs 2006; 66(17):2235–2254.
   PubMedGoogle Scholar
• Bailey W, Castro M, Matz J, White M, Dransfield M, Yancey S, Ortega H. Asthma exacerbations in African Americans treated for 1 year with combination fluticasone propionate and salmeterol or fluticasone propionate alone. Curr Med Res Opin 2008; 24(6):1669–1682.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136(1):225–244.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1995; 152(3):1107–1136.
   PubMed Web of Science ®Google Scholar
• Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR. Validation of a standardized version of the asthma quality of life questionnaire. Chest 1999; 115(5):1265–1270.
   PubMed Web of Science ®Google Scholar
• Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the Asthma Control Test: a survey for assessing asthma control. J Allergy Clin Immunol 2004; 113(1):59–65.
   PubMed Web of Science ®Google Scholar
• Schatz MS, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, Kosinski M, Pendergraft TB, Jhingran P. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 2006; 117(3):549–556.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Defining overweight and obesity. Available at: http://www.cdc.gov/obesity/defining.html. Accessed June 9, 2010.
   Google Scholar
• Chervinsky P, Baker J, Bensch G, Parasuraman B, Boggs R, Martin P, O’Dowd L. Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler. Ann Allergy Asthma Immunol 2008; 101(5):463–473.
   PubMedGoogle Scholar
• Murphy K, Nelson H, Parasuraman B, Boggs R, Miller C, O’Dowd L. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma. Curr Med Res Opin 2008; 24(3):879–894.
   PubMed Web of Science ®Google Scholar
• Boulet L-P, Franssen E. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med 2007; 101(11):2240–2247.
   PubMed Web of Science ®Google Scholar
• Lavoie KL, Bacon SL, Labrecque M, Cartier A, Ditto B. Higher BMI is associated with worse asthma control and quality of life but not asthma severity. Respir Med 2006; 100(4):648–657.
   PubMed Web of Science ®Google Scholar
• Gould W, Peterson EL, Karungi G, Zoratti A, Gaggin J, Toma G, Yan S, Levin AM, Yang JJ, Wells K, Wang M, Burke RR, Beckman K, Popadic D, Land SJ, Kumar R, Seibold MA, Lanfear DE, Burchard EG, Williams LK. Factors predicting inhaled corticosteroid responsiveness in African American patients with asthma. J Allergy Clin Immunol 2010; 126(6):1131–1138.
   PubMed Web of Science ®Google Scholar